Allspring Global Investments
KRTX

Allspring Global Investments’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Allspring Global Investments’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-102,086
Closed -$32.3M – 2448
2023
Q4 		$32.3M Buy
102,086
+1,057
+1% +$205K 0.05% 438
2023
Q3 		$17.1M Sell
101,029
-28,586
-22% -$5.37M 0.03% 593
2023
Q2 		$28.1M Buy
129,615
+80,832
+166% +$17.3M 0.04% 506
2023
Q1 		$8.86M Buy
48,783
+46,295
+1,861% +$8.85M 0.01% 820
2022
Q4 		$489K Buy
2,488
+1,225
+97% +$263K ﹤0.01% 1598
2022
Q3 		$284K Buy
1,263
+477
+61% +$96.5K ﹤0.01% 1720
2022
Q2 		$99K Sell
786
-5,664
-88% -$651K ﹤0.01% 2070
2022
Q1 		$817K Buy
6,450
+140
+2% +$15.8K ﹤0.01% 2003
2021
Q4 		$826K Buy
+6,310
New +$816K ﹤0.01% 2048

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Allspring Global Investments's KRTX Position: Q1 2024 in Review

Allspring Global Investments sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 102,086 shares — an estimated $32.3M sold.

Allspring Global Investments first reported a position in KRTX in Q4 2021 and held it in 9 quarters. The position peaked at $32.3M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Allspring Global Investments reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Allspring Global Investments sold 102,086 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $32.3M.
  • Allspring Global Investments first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's Karuna Therapeutics, Inc. Common Stock position peaked at $32.3M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Allspring Global Investments's 13F filing for Q1 2024, filed 18 Apr 2024.